| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Olfaction Disorders | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Pathologic Processes | |||||
| Sensation Disorders | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| Pentoxifylline retard 400mg | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Pentoxifylline | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antioxidants | |||||
| Cardiovascular Agents | |||||
| Enzyme Inhibitors | |||||
| Free Radical Scavengers | |||||
| Hematologic Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Phosphodiesterase Inhibitors | |||||
| Physiological Effects of Drugs | |||||
| Platelet Aggregation Inhibitors | |||||
| Protective Agents | |||||
| Radiation-Protective Agents | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 7 | Sponsors listed in this trial | ||||
| Dresden University of Technology | |||||
|
